First, we focused on cancer types known to have frequent activating mutations in KRAS or EGFR: colorectal adenocarcinoma (COAD) and glioblastoma multiforme (GBM), respectively (Cancer Genome Atlas Research Network, 2008; Cancer Genome Atlas Network, 2012). Here, EGFR is linked to glioblastoma.